全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Inhibitory Activities of Cyanidin and Its Glycosides and Synergistic Effect with Acarbose against Intestinal α-Glucosidase and Pancreatic α-Amylase

DOI: 10.3390/ijms11093387

Keywords: cyanidin glycosides, intestinal a-glucosidase, pancreatic a-amylase, synergism

Full-Text   Cite this paper   Add to My Lib

Abstract:

Cyanidin and its glycosides are naturally dietary pigments which have been indicated as promising candidates to have potential benefits to humans, especially in the prevention and treatment of diabetes mellitus. We investigated the structure activity relationships of cyanidin and its glycosides to inhibit intestinal a-glucosidases and pancreatic a-amylase in vitro. The results found that cyanidin and its glycosides are more specific inhibitors of intestinal sucrase than intestinal maltase. Cyanidin-3-galactoside and cyanidin-3-glucoside were the most potent inhibitors against intestinal sucrase and pancreatic a-amylase with IC 50 values of 0.50?±?0.05 and 0.30?± 0.01 mM, respectively. Our findings indicate that the structural difference between glucose and galactose at the 3- O-position of cyanidin was an important factor for modulating the inhibition of intestinal sucrase and pancreatic a-amylase. The combination of cyandin-3-glucoside, cyanidin-3-galactoside or cyanidin-3,5-diglucosides with a low concentration of acarbose showed synergistic inhibition on intestinal maltase and sucrase. The synergistic inhibition was also found for a combination of cyanidin or cyanidin-3-glucoside with a low concentration of acarbose. The findings could provide a new insight into a use for the naturally occurring intestinal a-glucosidase and pancreatic a-amylase inhibitors for the prevention and treatment of diabetes and its complications.

References

[1]  Zafra-Stone, S; Yasmin, T; Bagchi, M; Chatterjee, A; Vinson, JA; Bagchi, D. Berry anthocyanins as novel antioxidants in human health and disease prevention. Mol. Nutr. Food Res?2007, 51, 675–683.
[2]  Xia, X; Ling, W; Ma, J; Xia, M; Hou, M; Wang, Q; Zhu, H; Tang, Z. An anthocyanin-rich extract from black rice enhances atherosclerotic plaque stabilization in apolipoprotein E-deficient mice. J. Nutr?2006, 136, 2220–2225.
[3]  Qin, Y; Xia, M; Ma, J; Hao, Y; Liu, J; Mou, H; Cao, L; Ling, W. Anthocyanin supplementation improves serum LDL- and HDL-cholesterol concentrations associated with the inhibition of cholesteryl ester transfer protein in dyslipidemic subjects. Am. J. Clin. Nutr?2009, 90, 485–492.
[4]  Ghosh, D; Konishi, T. Anthocyanins and anthocyanin-rich extracts: Role in diabetes and eye function. Asia Pac. J. Clin. Nutr?2007, 16, 200–208.
[5]  McDougall, GJ; Stewart, D; McDougall, GJ; Stewart, D. The inhibitory effects of berry polyphenols on digestive enzymes. Biofactors?2005, 23, 189–195.
[6]  Chiasson, JL; Josse, RG; Gomis, R; Hanefeld, M; Karasik, A; Laakso, M. STOP-NIDDM trial research group. Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: Facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data. Lancet?2002, 359, 2072–2077.
[7]  Galvano, F; La Fauci, L; Vitaglione, P; Fogliano, V; Vanella, L; Felgines, C. Bioavailability, antioxidant and biological properties of the natural free-radical scavengers cyanidin and related glycosides. Ann. Ist. Super. Sanita?2007, 43, 382–393.
[8]  Adisakwattana, S; Charoenlertkul, P; Yibchok-Anun, S. alpha-Glucosidase inhibitory activity of cyanidin-3-galactoside and synergistic effect with acarbose. J. Enzyme Inhib. Med. Chem?2009, 24, 65–69.
[9]  Adisakwattana, S; Ngamrojanavanich, N; Kalampakorn, K; Tiravanit, W; Roengsumran, S; Yibchok-Anun, S. Inhibitory activity of cyanidin-3-rutinoside on alpha-glucosidase. J. Enzyme Inhib. Med. Chem?2004, 19, 313–316.
[10]  Adisakwattana, S; Chantarasinlapin, P; Thammarat, H; Yibchok-Anun, S. A series of cinnamic acid derivatives and their inhibitory activity on intestinal alpha-glucosidase. J. Enzyme. Inhib. Med. Chem?2009, 24, 1194–1200.
[11]  Lo Piparo, E; Scheib, H; Frei, N; Williamson, G; Grigorov, M; Chou, CJ. Flavonoids for controlling starch digestion: Structural requirements for inhibiting human alpha-amylase. J. Med. Chem?2008, 51, 3555–3561.
[12]  Abdel-Aal, SM; Young, JC; Rabalski, I. Anthocyanin composition in black, blue, pink, purple, and red cereal grains. J. Agric. Food. Chem?2006, 54, 4696–4704.
[13]  Kano, M; Takayanagi, T; Harada, K; Makino, K; Ishikawa, F. Antioxidative activity of anthocyanins from purple sweet potato, Ipomoera batatas cultivar Ayamurasaki. Biosci. Biotechnol. Biochem?2005, 69, 979–988.
[14]  Sasaki, R; Nishimura, N; Hoshino, H; Isa, Y; Kadowaki, M; Ichi, T; Tanaka, A; Nishiumi, S; Fukuda, I; Ashida, H; Horio, F; Tsuda, T. Cyanidin 3-glucoside ameliorates hyperglycemia and insulin sensitivity due to downregulation of retinol binding protein 4 expression in diabetic mice. Biochem. Pharmacol?2007, 74, 1619–1627.
[15]  Guo, H; Ling, W; Wang, Q; Liu, C; Hu, Y; Xia, M. Cyanidin 3-glucoside protects 3T3-L1 adipocytes against H2O2- or TNF-alpha-induced insulin resistance by inhibiting c-Jun NH2-terminal kinase activation. Biochem. Pharmacol?2008, 75, 1393–1401.
[16]  Jayaprakasam, B; Vareed, SK; Olson, LK; Nair, MG. Insulin Secretion by Bioactive Anthocyanins and Anthocyanidins Present in Fruits. J. Agric. Food Chem?2005, 53, 28–31.
[17]  Baron, AD. Postprandial hyperglycaemia and alpha-glucosidase inhibitors. Diabetes Res. Clin. Pract?1998, 40, S51–S55.
[18]  Chiasson, JL. Acarbose for the prevention of diabetes, hypertension, and cardiovascular disease in subjects with impaired glucose tolerance: The Study to Prevent Non-Insulin-Dependent Diabetes Mellitus (STOP-NIDDM) Trial. Endocr. Pract?2006, 12, S25–S30.
[19]  Hanefeld, M; Fischer, S; Schulze, J; Spengler, M; Wargenau, M; Schollberg, K; Fücker, K. Therapeutic potentials of acarbose as first-line drug in NIDDM insufficiently treated with diet alone. Diabetes Care?1991, 14, 732–737.
[20]  Rodier, M; Richard, JL; Monnier, L; Mirauze, J. Effect of long term acarbose (Bay g 5421) therapy on metabolic control on non-insulin-dependent (type II) diabetes mellitus. Diabetes Met?1988, 14, 12–14.
[21]  Santeusanio, F; Ventura, MM; Contadinbi, S. Efficacy and safety of two different dosages of acarbose in non-insulin dependent diabetic patients treated by diet alone. Diabetes Nutr. Metab?1993, 6, 147–154.
[22]  Frank, J; Kamal-Eldin, A; Lundh, T; M??tt?, K; T?rr?nen, R; Vessby, B. Effects of dietary anthocyanins on tocopherols and lipids in rats. J. Agric. Food Chem?2002, 50, 7226–7230.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133